Real-time enrollment status for this polymyalgia rheumatica clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 8:01 AM UTC
| NCT Number | NCT06331312 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Polymyalgia Rheumatica |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | April 16, 2026 (Yesterday) |
As of April 17, 2026: Clinical trial NCT06331312 is currently active_not_recruiting participants. This clinical trial study for polymyalgia rheumatica is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06331312 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06331312 was last updated Yesterday (April 16, 2026). HelloStudys verifies this status automatically.